Search Results - "Neves, Karla B."

Refine Results
  1. 1

    Vascular toxicity associated with anti-angiogenic drugs by Neves, Karla B, Montezano, Augusto C, Lang, Ninian N, Touyz, Rhian M

    Published in Clinical science (1979) (30-09-2020)
    “…Over the past two decades, the treatment of cancer has been revolutionised by the highly successful introduction of novel molecular targeted therapies and…”
    Get more information
    Journal Article
  2. 2

    Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients by van Dorst, Daan C.H., Dobbin, Stephen J.H., Neves, Karla B., Herrmann, Joerg, Herrmann, Sandra M., Versmissen, Jorie, Mathijssen, Ron H.J., Danser, A.H. Jan, Lang, Ninian N.

    Published in Circulation research (02-04-2021)
    “…The development of a wide range of novel antineoplastic therapies has improved the prognosis for patients with a wide range of malignancies, which has…”
    Get full text
    Journal Article
  3. 3

    Tissue sodium excess is not hypertonic and reflects extracellular volume expansion by Rossitto, Giacomo, Mary, Sheon, Chen, Jun Yu, Boder, Philipp, Chew, Khai Syuen, Neves, Karla B., Alves, Rheure L., Montezano, Augusto C., Welsh, Paul, Petrie, Mark C., Graham, Delyth, Touyz, Rhian M., Delles, Christian

    Published in Nature communications (24-08-2020)
    “…Our understanding of Na + homeostasis has recently been reshaped by the notion of skin as a depot for Na + accumulation in multiple cardiovascular diseases and…”
    Get full text
    Journal Article
  4. 4

    Downregulation of Nuclear Factor Erythroid 2-Related Factor and Associated Antioxidant Genes Contributes to Redox-Sensitive Vascular Dysfunction in Hypertension by Lopes, Rhéure A, Neves, Karla B, Tostes, Rita C, Montezano, Augusto C, Touyz, Rhian M

    Published in Hypertension (Dallas, Tex. 1979) (01-12-2015)
    “…Oxidative stress is implicated in vascular dysfunction in hypertension. Although mechanisms regulating vascular pro-oxidants are emerging, there is a paucity…”
    Get full text
    Journal Article
  5. 5

    Perivascular Adipose Tissue as a Relevant Fat Depot for Cardiovascular Risk in Obesity by Costa, Rafael M, Neves, Karla B, Tostes, Rita C, Lobato, Núbia S

    Published in Frontiers in physiology (21-03-2018)
    “…Obesity is associated with increased risk of premature death, morbidity, and mortality from several cardiovascular diseases (CVDs), including stroke, coronary…”
    Get full text
    Journal Article
  6. 6

    Crosstalk Between Vascular Redox and Calcium Signaling in Hypertension Involves TRPM2 (Transient Receptor Potential Melastatin 2) Cation Channel by Alves-Lopes, Rhéure, Neves, Karla B., Anagnostopoulou, Aikaterini, Rios, Francisco J., Lacchini, Silvia, Montezano, Augusto C., Touyz, Rhian M.

    Published in Hypertension (Dallas, Tex. 1979) (01-01-2020)
    “…Increased generation of reactive oxygen species (ROS) and altered Ca2+ handling cause vascular damage in hypertension. Mechanisms linking these systems are…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO/sGC/cGMP pathway by Neves, Karla B, Morris, Hannah E, Alves-Lopes, Rhéure, Muir, Keith W, Moreton, Fiona, Delles, Christian, Montezano, Augusto C, Touyz, Rhian M

    Published in Clinical science (1979) (26-03-2021)
    “…Notch3 mutations cause Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), which predisposes to stroke and…”
    Get more information
    Journal Article
  12. 12

    Role of PARP and TRPM2 in VEGF Inhibitor-Induced Vascular Dysfunction by Neves, Karla B, Alves-Lopes, Rheure, Montezano, Augusto C, Touyz, Rhian M

    Published in Journal of the American Heart Association (21-02-2023)
    “…Background Hypertension and vascular toxicity are major unwanted side effects of antiangiogenic drugs, such as vascular endothelial growth factor inhibitors…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer by Cameron, Alan C., McMahon, Kelly, Hall, Mark, Neves, Karla B., Rios, Francisco J., Montezano, Augusto C., Welsh, Paul, Waterston, Ashita, White, Jeff, Mark, Patrick B., Touyz, Rhian M., Lang, Ninian N.

    Published in JACC CardioOncology (01-09-2020)
    “…Cisplatin-based chemotherapy increases the risk of cardiovascular and renal disease. We aimed to define the time course, pathophysiology, and approaches to…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Functional and structural changes in internal pudendal arteries underlie erectile dysfunction induced by androgen deprivation by Alves-Lopes, Rh Ure, Neves, Karla B, Silva, Marcondes Ab, Olivon, Vânia C, Ruginsk, Silvia G, Antunes-Rodrigues, José, Ramalho, Leandra Nz, Tostes, Rita C, Carneiro, Fernando Silva

    Published in Asian journal of andrology (01-09-2017)
    “…Androgen deficiency is strongly associated with erectile dysfunction (ED). Inadequate penile arterial blood flow is one of the major causes of ED. The blood…”
    Get full text
    Journal Article
  18. 18

    Testosterone and vascular function in aging by Lopes, Rhéure A M, Neves, Karla B, Carneiro, Fernando S, Tostes, Rita C

    Published in Frontiers in physiology (01-01-2012)
    “…Androgen receptors are widely distributed in several tissues, including vascular endothelial and smooth muscle cells. Through classic cytosolic androgen…”
    Get full text
    Journal Article
  19. 19

    Oxidative Stress: A Unifying Paradigm in Hypertension by Touyz, Rhian M., Rios, Francisco J., Alves-Lopes, Rhéure, Neves, Karla B., Camargo, Livia L., Montezano, Augusto C.

    Published in Canadian journal of cardiology (01-05-2020)
    “…The etiology of hypertension involves complex interactions among genetic, environmental, and pathophysiologic factors that influence many regulatory systems…”
    Get full text
    Journal Article
  20. 20

    VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive Processes by Neves, Karla B, Rios, Francisco J, van der Mey, Lucas, Alves-Lopes, Rheure, Cameron, Alan C, Volpe, Massimo, Montezano, Augusto C, Savoia, Carmine, Touyz, Rhian M

    Published in Hypertension (Dallas, Tex. 1979) (01-04-2018)
    “…Although VEGF (vascular endothelial growth factor) inhibitors (VEGFIs), are effective anticancer therapies, they cause hypertension through unknown mechanisms…”
    Get full text
    Journal Article